DCGO - DocGo Inc. Stock Analysis | Stock Taper
Logo
DocGo Inc.

DCGO

DocGo Inc. NASDAQ
$0.65 10.95% (+0.06)

Market Cap $64.06 M
52w High $2.45
52w Low $0.49
P/E -0.35
Volume 2.25M
Outstanding Shares 98.75M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $74.94M $56.81M $-134.07M -178.91% $-1.37 $-28.49M
Q3-2025 $70.81M $60.1M $-27.77M -39.22% $-0.28 $-21.27M
Q2-2025 $80.42M $42.9M $-11.16M -13.87% $-0.11 $-13.49M
Q1-2025 $96.03M $44.85M $-9.41M -9.79% $-0.09 $-10.62M
Q4-2024 $120.83M $47.97M $-3.26M -2.7% $-0.03 $-3.16M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $51.02M $217.1M $91.23M $144.01M
Q3-2025 $73.36M $353.78M $93.12M $270.53M
Q2-2025 $104.16M $408.26M $120.53M $297.28M
Q1-2025 $79.01M $430.79M $128.87M $309.34M
Q4-2024 $89.24M $455.62M $140.44M $320.92M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $-142.34M $-10.47M $-13.07M $-1.86M $-25.12M $-12.6M
Q3-2025 $-29.66M $1.66M $1.1M $-33.05M $-30.95M $101.16K
Q2-2025 $-13.29M $33.6M $-21.38M $-7.38M $5.5M $32.04M
Q1-2025 $-11.08M $9.66M $-5.73M $-8.52M $-4.28M $7.47M
Q4-2024 $-7.65M $12.89M $-5.57M $-7.86M $-1.24M $12.22M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q4-2025
Mobile Health Services Segment
Mobile Health Services Segment
$70.00M $50.00M $30.00M $50.00M
Transportation Services Segment
Transportation Services Segment
$50.00M $50.00M $50.00M $100.00M

Revenue by Geography

Region Q4-2024Q1-2025Q2-2025Q4-2025
UNITED KINGDOM
UNITED KINGDOM
$20.00M $10.00M $10.00M $30.00M
UNITED STATES
UNITED STATES
$110.00M $80.00M $70.00M $120.00M

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at DocGo Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

DocGo combines a meaningful revenue base, strong liquidity, and a distinctive strategic position in mobile and virtual healthcare. Its balance sheet shows ample cash and modest leverage, giving it time to refine its model. The company’s proprietary technology platform, hybrid care capabilities, and focus on “last-mile” healthcare delivery create clear differentiation in a market that increasingly values home-based and preventive care. Positive operating and free cash flow, despite large accounting losses, indicate some underlying operational resilience and support continued investment in innovation.

! Risks

The largest risks are financial and execution-related. Profitability is deeply negative, and accumulated losses are significant, reflecting a cost structure that currently outstrips the economics of its contracts. If operating expenses—especially overhead and technology investments—are not brought into better balance with gross profit, the current cash cushion could erode over time. Competitive and regulatory pressures add further uncertainty: powerful incumbents, contract concentration, reimbursement changes, and operational complexity all pose challenges. The ambitious innovation agenda also carries execution risk; integrating acquisitions, deploying AI, and scaling complex services without compromising quality is difficult.

Outlook

The outlook for DocGo is mixed but strategically interesting. On one side, the company is aligned with powerful trends toward in-home care, telehealth, and cost containment, and it has built technology and service capabilities that many healthcare stakeholders are actively seeking. Management’s stated intent to pivot toward higher-margin business and achieve adjusted EBITDA profitability suggests a focus on improving economics. On the other side, current financials show that this transition is still in progress, with substantial losses and a need for disciplined cost management. The path forward will likely hinge on DocGo’s ability to convert its innovative model and strong customer value proposition into consistent, scalable profitability while preserving its balance sheet strength.